| Period Ending | Mar 30, 2005 |
|---|
|
Total Revenue
|
5,151
| | Cost of Revenue | 1,519 | | |
Gross Profit
|
3,632
| |
|
Operating Expenses |
|
Research Development | 662 |
|
Selling General and Administrative | 2,638 |
|
Non Recurring |
-
|
|
Others |
-
|
|
|
|
Total Operating Expenses |
-
| | | |
Operating Income or Loss
|
332
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 94 |
|
Earnings Before Interest And Taxes | 426 |
|
Interest Expense |
-
|
|
Income Before Tax | 426 |
|
Income Tax Expense | 123 |
|
Minority Interest |
-
|
|
|
|
Net Income From Continuing Ops | 303 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | | |
Net Income
|
303
| | Preferred Stock And Other Adjustments |
-
| | |
Net Income Applicable To Common Shares
|
303
|
|
0.43 (0.44%) 8:00AM EDT - Nasdaq Real Time Price